Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Jones

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
The American Journal of Tropical Medicine and Hygiene|February 1, 1997
Plasmodium falciparum gametocytemia in Kenyan children: associations among age, intensity of exposure to transmission, and prevalence and density of subsequent gametocytemiaT R Jones, P D McElroy, C N Oster, et al.
Infection and Immunity|October 26, 1999
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte proteinY Charoenvit, V F Majam, G Corradin, et al.
Journal of Medicinal Chemistry|October 1, 1985
Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituentT R Jones, A H Calvert, A L Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717A H Calvert, D L Alison, S J Harland, et al.
Journal of Medicinal Chemistry|November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 positionL R Hughes, A L Jackman, J Oldfield, et al.
Journal of Virology|January 1, 1996
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infectionJ A Kerry, M A Priddy, T Y Jervey, et al.
Biochemistry|May 7, 1996
Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formationE Z Baum, M M Siegel, G A Bebernitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 1999
Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, IndonesiaW R Taylor, T L Richie, D J Fryauff, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitorsR Frenette, J H Hutchinson, S Léger, et al.
Vaccine|September 13, 2015
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccineK A Bryant, R Frenck, A Gurtman, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
The American Journal of Tropical Medicine and Hygiene|February 1, 1997
Plasmodium falciparum gametocytemia in Kenyan children: associations among age, intensity of exposure to transmission, and prevalence and density of subsequent gametocytemiaT R Jones, P D McElroy, C N Oster, et al.
Infection and Immunity|October 26, 1999
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte proteinY Charoenvit, V F Majam, G Corradin, et al.
Journal of Medicinal Chemistry|October 1, 1985
Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituentT R Jones, A H Calvert, A L Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717A H Calvert, D L Alison, S J Harland, et al.
Journal of Medicinal Chemistry|November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 positionL R Hughes, A L Jackman, J Oldfield, et al.
Journal of Virology|January 1, 1996
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infectionJ A Kerry, M A Priddy, T Y Jervey, et al.
Biochemistry|May 7, 1996
Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formationE Z Baum, M M Siegel, G A Bebernitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 1999
Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, IndonesiaW R Taylor, T L Richie, D J Fryauff, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitorsR Frenette, J H Hutchinson, S Léger, et al.
Vaccine|September 13, 2015
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccineK A Bryant, R Frenck, A Gurtman, et al.
Pageof 22